One of the primary advantages of T Cell Engagers is their ability to harness the body's own immune system to fight cancer, offering a mechanism of action that differs from traditional therapies like chemotherapy and radiation. Additionally, T Cell Engagers can be engineered to target specific antigens, potentially reducing off-target effects and improving efficacy.
